Patients News | pharmaphorum

News

AI medtech specialist Firefly lists on Nasdaq after merger

Canada's Firefly Neuroscience has completed a listing on the Nasdaq via a $45 million reverse merger with IT group WaveDancer, opening up new financing routes for its artificial intelligenc

News

Africa on high alert as mpox cases rise quickly

The rapid spread of a new variant of mpox – previously known as monkeypox – has prompted the Africa Centers for Disease Control and Prevention (Africa CDC) to declare a public health emerge

News

prescription digital therapeutic on a smartphone

Otsuka, Click's depression DTx launches in the US

An FDA-approved digital therapeutic (DTx) that can be used to help people living with major depressive disorder (MDD) has been launched in the US and is available in mobile app stores.

News

Multiple hands raised against multi-colour background

UK drive for research, trial subjects hits key milestone

More than half a million people in the UK have signed up to participate in studies in response to a campaign launched two years ago to revitalise the country's role as a hub for research.

News

After a no in sickle cell, NICE OKs Casgevy for thalassaemia

Vertex and CRISPR Therapeutics have won the backing of NICE for their gene-editing therapy Casgevy as a treatment for the blood disorder beta thalassaemia, a few months after turning it dow

News